{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:32:19Z","timestamp":1794619939725,"version":"4.9.1"},"reference-count":53,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,2]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Steroid-refractory (SR) disease develops in a substantial fraction of patients with grade II to IV acute graft-versus-host disease (aGVHD) and is associated with poor long-term survival. Improved mechanistic insight is needed to identify reliable predictors of steroid resistance. We retrospectively profiled peripheral blood collected before glucocorticoid treatment from allogeneic hematopoietic cell transplantation recipients without aGVHD, with steroid-sensitive aGVHD, and with SR-aGVHD using an integrated multiomics approach, and validated our findings in an independent multicenter cohort. Mass cytometry revealed an expansion of activated CD28+ CD8+ effector-memory T (Tem) cells in SR-aGVHD. Absolute counts of these cells at neutrophil engraftment predicted subsequent steroid resistance in the multicenter cohort and performed comparably to established clinical classifiers. This phenotype was associated with a proinflammatory milieu enriched in interleukin-2 (IL-2), IL-27, and interferon gamma. Single-cell RNA sequencing and functional assays implicated a STAT1\u2013glucocorticoid receptor (GR) regulatory axis, in which inflammatory cytokines induce STAT1 phosphorylation and suppress GR expression, consistent with intrinsic glucocorticoid resistance. JAK inhibition rescued cytokine-induced steroid resistance in vitro, whereas in patients with SR-aGVHD, clinical response to ruxolitinib was accompanied by reduced STAT1 activation, restoration of GR expression, and contraction of the expanded CD8+ Tem cell pool. These findings identify immune dysregulation in SR-aGVHD centered on CD8+ Tem cells with a STAT1-dependent GR deficit and support a mechanistic link to steroid refractoriness. CD28+ CD8+ Tem cell counts may serve as a biomarker of SR-aGVHD and inform the development of preemptive, pathway-targeted therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025032587","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T17:12:28Z","timestamp":1776186748000},"page":"130-144","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":3,"title":["CD28+ CD8+ Tem cells with a STAT1-dependent glucocorticoid receptor deficit contribute to steroid-refractory acute GVHD"],"prefix":"10.1182","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0373-2632","authenticated-orcid":false,"given":"Zengkai","family":"Pan","sequence":"first","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"2Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3577-9993","authenticated-orcid":false,"given":"Yujun","family":"Deng","sequence":"additional","affiliation":[{"name":"3Center for Immunology and Hematology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Collaborative Innovation Center for Biotherapy, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4462-758X","authenticated-orcid":false,"given":"Jingtao","family":"Huang","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"2Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"4State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxing","family":"Bian","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"2Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyin","family":"Chen","sequence":"additional","affiliation":[{"name":"5National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Jiangsu Key Laboratory of Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou, China"},{"name":"6Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9689-1335","authenticated-orcid":false,"given":"Aijie","family":"Huang","sequence":"additional","affiliation":[{"name":"7Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanhe","family":"Jiang","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"2Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luxiang","family":"Wang","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"2Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilu","family":"Zhang","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"2Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Lu","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"2Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Li","sequence":"additional","affiliation":[{"name":"8Department of Hematology, Shanghai Liquan Hospital, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Yin","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"2Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanhe","family":"Yu","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"2Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Zhu","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"2Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6834-1616","authenticated-orcid":false,"given":"Wei-Li","family":"Zhao","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"2Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Wang","sequence":"additional","affiliation":[{"name":"7Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ji","sequence":"additional","affiliation":[{"name":"9Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China"},{"name":"10Stem Cell Transplantation & Cellular Therapy Division, Clinic Trial Center, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xu","sequence":"additional","affiliation":[{"name":"5National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Jiangsu Key Laboratory of Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou, China"},{"name":"6Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9154-9282","authenticated-orcid":false,"given":"Hui","family":"Cheng","sequence":"additional","affiliation":[{"name":"4State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"},{"name":"11Department of Stem Cell and Regenerative Medicine, Center for Stem Cell Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7719-3216","authenticated-orcid":false,"given":"Jiahao","family":"Chen","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"2Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Hu","sequence":"additional","affiliation":[{"name":"3Center for Immunology and Hematology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Collaborative Innovation Center for Biotherapy, Chengdu, China"},{"name":"12Chongqing International Institute for Immunology, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Hu","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"2Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"22","key":"2026070211220692500_bib1","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra1609337","article-title":"Acute graft-versus-host disease - biologic process, prevention, and therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"2026070211220692500_bib2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1182\/blood.2019000953","article-title":"Immunopathology and biology-based treatment of steroid-refractory graft-versus-host disease","volume":"136","author":"Toubai","year":"2020","journal-title":"Blood"},{"issue":"15","key":"2026070211220692500_bib3","doi-asserted-by":"crossref","first-page":"e162201","DOI":"10.1172\/JCI162201","article-title":"Ruxolitinib improves hematopoietic regeneration by restoring mesenchymal stromal cell function in acute graft-versus-host disease","volume":"133","author":"Lin","year":"2023","journal-title":"J Clin Invest"},{"issue":"1","key":"2026070211220692500_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transpl"},{"issue":"6","key":"2026070211220692500_bib5","first-page":"825","article-title":"1994 Consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transpl"},{"issue":"17","key":"2026070211220692500_bib6","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1200\/JCO.20.01086","article-title":"Phase II trial of costimulation blockade with abatacept for prevention of acute GVHD","volume":"39","author":"Watkins","year":"2021","journal-title":"J Clin Oncol"},{"issue":"2","key":"2026070211220692500_bib7","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1470-2045(15)00462-3","article-title":"Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial","volume":"17","author":"Walker","year":"2016","journal-title":"Lancet Oncol"},{"issue":"2","key":"2026070211220692500_bib8","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/S2352-3026(23)00342-3","article-title":"Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation","volume":"11","author":"Penack","year":"2024","journal-title":"Lancet Haematol"},{"issue":"5","key":"2026070211220692500_bib9","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/s41375-020-0804-2","article-title":"Treatment and unmet needs in steroid-refractory acute graft-versus-host disease","volume":"34","author":"Malard","year":"2020","journal-title":"Leukemia"},{"issue":"9","key":"2026070211220692500_bib10","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1182\/blood.2024025106","article-title":"Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD","volume":"144","author":"Akahoshi","year":"2024","journal-title":"Blood"},{"issue":"5","key":"2026070211220692500_bib11","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1182\/bloodadvances.2020003937","article-title":"Steroid-dependent acute GVHD after allogeneic hematopoietic cell transplantation: risk factors and clinical outcomes","volume":"5","author":"El Jurdi","year":"2021","journal-title":"Blood Adv"},{"issue":"1","key":"2026070211220692500_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41409-020-0977-3","article-title":"Long-term outcomes and risk factor analysis of steroid-refractory graft versus host disease after hematopoietic stem cell transplantation","volume":"56","author":"Pagliuca","year":"2021","journal-title":"Bone Marrow Transpl"},{"issue":"9678","key":"2026070211220692500_bib13","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/S0140-6736(09)60326-3","article-title":"Glucocorticoid resistance in inflammatory diseases","volume":"373","author":"Barnes","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"2026070211220692500_bib14","doi-asserted-by":"crossref","first-page":"e13901","DOI":"10.1111\/eci.13901","article-title":"Molecular mechanisms of glucocorticoid resistance","volume":"53","author":"Huang","year":"2023","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"2026070211220692500_bib15","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41467-021-21133-3","article-title":"IL-22-dependent dysbiosis and mononuclear phagocyte depletion contribute to steroid-resistant gut graft-versus-host disease in mice","volume":"12","author":"Song","year":"2021","journal-title":"Nat Commun"},{"issue":"15","key":"2026070211220692500_bib16","doi-asserted-by":"crossref","first-page":"e165723","DOI":"10.1172\/JCI165723","article-title":"Donor T cell STAT3 deficiency enables tissue PD-L1-dependent prevention of graft-versus-host disease while preserving graft-versus-leukemia activity","volume":"133","author":"Li","year":"2023","journal-title":"J Clin Invest"},{"issue":"1","key":"2026070211220692500_bib17","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41467-024-44703-7","article-title":"ROCK1\/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease","volume":"15","author":"Maas-Bauer","year":"2024","journal-title":"Nat Commun"},{"issue":"20","key":"2026070211220692500_bib18","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1182\/blood.2020004823","article-title":"Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial","volume":"135","author":"Jagasia","year":"2020","journal-title":"Blood"},{"issue":"19","key":"2026070211220692500_bib19","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa1917635","article-title":"Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease","volume":"382","author":"Zeiser","year":"2020","journal-title":"N Engl J Med"},{"issue":"13","key":"2026070211220692500_bib20","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1182\/bloodadvances.2024012561","article-title":"The MAGIC Algorithm Probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD","volume":"8","author":"DeFilipp","year":"2024","journal-title":"Blood Adv"},{"issue":"11","key":"2026070211220692500_bib21","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.3324\/haematol.2022.281269","article-title":"Minnesota acute graft-versus-host disease risk score predicts survival at onset of graft-versus-host disease after post-transplant cyclophosphamide prophylaxis","volume":"107","author":"Ardizzoia","year":"2022","journal-title":"Haematologica"},{"issue":"1","key":"2026070211220692500_bib22","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2352-3026(14)00035-0","article-title":"A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study","volume":"2","author":"Levine","year":"2015","journal-title":"Lancet Haematol"},{"issue":"3","key":"2026070211220692500_bib23","doi-asserted-by":"crossref","first-page":"e89798","DOI":"10.1172\/jci.insight.89798","article-title":"An early-biomarker algorithm predicts lethal graft-versus-host disease and survival","volume":"2","author":"Hartwell","year":"2017","journal-title":"JCI Insight"},{"issue":"10","key":"2026070211220692500_bib24","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1002\/ajh.27020","article-title":"The MAGIC Algorithm Probability (MAP)-guided preemptive therapy of acute graft versus host disease with methylprednisolone: a randomized controlled trial","volume":"98","author":"Zeng","year":"2023","journal-title":"Am J Hematol"},{"issue":"11","key":"2026070211220692500_bib25","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/s41409-018-0204-7","article-title":"EBMT\u2212NIH\u2212CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment","volume":"53","author":"Schoemans","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"2026070211220692500_bib26","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.bbmt.2015.01.001","article-title":"A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality","volume":"21","author":"MacMillan","year":"2015","journal-title":"Biol Blood Marrow Transpl"},{"issue":"9674","key":"2026070211220692500_bib27","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"issue":"6","key":"2026070211220692500_bib28","doi-asserted-by":"crossref","first-page":"e2117031119","DOI":"10.1073\/pnas.2117031119","article-title":"Convergent clonal selection of donor- and recipient-derived CMV-specific T cells in hematopoietic stem cell transplant patients","volume":"119","author":"Erickson","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"649","key":"2026070211220692500_bib29","doi-asserted-by":"crossref","first-page":"eabo0686","DOI":"10.1126\/scitranslmed.abo0686","article-title":"Granzyme K(+) CD8 T cells form a core population in inflamed human tissue","volume":"14","author":"Jonsson","year":"2022","journal-title":"Sci Transl Med"},{"issue":"8","key":"2026070211220692500_bib30","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.it.2025.06.003","article-title":"GZMK(+)CD8(+) T cells: multifaceted roles beyond cytotoxicity","volume":"46","author":"Guo","year":"2025","journal-title":"Trends Immunol"},{"issue":"94","key":"2026070211220692500_bib31","doi-asserted-by":"crossref","first-page":"eadh0085","DOI":"10.1126\/sciimmunol.adh0085","article-title":"Targeted depletion of PD-1-expressing cells induces immune tolerance through peripheral clonal deletion","volume":"9","author":"Cui","year":"2024","journal-title":"Sci Immunol"},{"issue":"9","key":"2026070211220692500_bib32","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1182\/blood.2024027239","article-title":"A single dose of a CD137 antibody-drug conjugate protects rhesus macaque allogeneic HCT recipients against acute GVHD","volume":"146","author":"Gerdemann","year":"2025","journal-title":"Blood"},{"issue":"8","key":"2026070211220692500_bib33","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1186\/gb-2011-12-8-r83","article-title":"Cistrome: an integrative platform for transcriptional regulation studies","volume":"12","author":"Liu","year":"2011","journal-title":"Genome Biol"},{"issue":"12","key":"2026070211220692500_bib34","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood.2023020073","article-title":"Novel developments in the prophylaxis and treatment of acute GVHD","volume":"142","author":"Jamy","year":"2023","journal-title":"Blood"},{"issue":"7","key":"2026070211220692500_bib35","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1158\/2159-8290.CD-23-1266","article-title":"IL2 targeted to CD8+ T cells promotes robust effector T-cell responses and potent antitumor immunity","volume":"14","author":"Moynihan","year":"2024","journal-title":"Cancer Discov"},{"key":"2026070211220692500_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.it.2025.10.012","article-title":"Reframing IL-27: a central regulator of CD8(+) T cell immunity","author":"Venzin","year":"2026;47(4):272-283","journal-title":"Trends Immunol"},{"issue":"3","key":"2026070211220692500_bib37","doi-asserted-by":"crossref","first-page":"e125986","DOI":"10.1172\/JCI125986","article-title":"IFN-\u03b3R\/STAT1 signaling in recipient hematopoietic antigen-presenting cells suppresses graft-versus-host disease","volume":"133","author":"Lu","year":"2023","journal-title":"J Clin Invest"},{"issue":"3","key":"2026070211220692500_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2020.08.005","article-title":"Endogenous glucocorticoid signaling regulates CD8(+) T cell differentiation and development of dysfunction in the tumor microenvironment","volume":"53","author":"Acharya","year":"2020","journal-title":"Immunity"},{"key":"2026070211220692500_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/iji.12380","article-title":"The influence of glucocorticoid receptor single nucleotide polymorphisms on outcome after haematopoietic stem cell transplantation","author":"Norden","year":"2018;45(5):247-256","journal-title":"Int J Immunogenet"},{"issue":"7","key":"2026070211220692500_bib40","doi-asserted-by":"crossref","first-page":"e155880","DOI":"10.1172\/JCI155880","article-title":"Corticosteroids impair epithelial regeneration in immune-mediated intestinal damage","volume":"134","author":"Arnhold","year":"2024","journal-title":"J Clin Invest"},{"issue":"22","key":"2026070211220692500_bib41","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1182\/blood-2014-06-577023","article-title":"Phase 3 clinical trial of steroids\/mycophenolate mofetil vs steroids\/placebo as therapy for acute GVHD: BMT CTN 0802","volume":"124","author":"Bola\u00f1os-Meade","year":"2014","journal-title":"Blood"},{"issue":"5","key":"2026070211220692500_bib42","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1182\/blood-2004-03-0854","article-title":"Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial","volume":"104","author":"Lee","year":"2004","journal-title":"Blood"},{"issue":"12","key":"2026070211220692500_bib43","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.bbmt.2009.08.003","article-title":"A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease","volume":"15","author":"Couriel","year":"2009","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"2026070211220692500_bib44","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/S2352-3026(21)00367-7","article-title":"Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301): a randomised, multicentre, double-blind, phase 3 trial","volume":"9","author":"Zeiser","year":"2022","journal-title":"Lancet Haematol"},{"issue":"2","key":"2026070211220692500_bib45","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3324\/haematol.2019.220970","article-title":"Validation of Minnesota acute graft-versus-host disease risk score","volume":"105","author":"MacMillan","year":"2020","journal-title":"Haematologica"},{"issue":"1","key":"2026070211220692500_bib46","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41392-024-01987-x","article-title":"Ruxolitinib plus steroids for acute graft versus host disease: a multicenter, randomized, phase 3 trial","volume":"9","author":"Dou","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"2026070211220692500_bib47","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nri.2016.38","article-title":"T cell responses to cytomegalovirus","volume":"16","author":"Klenerman","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2026070211220692500_bib48","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1182\/bloodadvances.2020003005","article-title":"Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide","volume":"5","author":"Rambaldi","year":"2021","journal-title":"Blood Adv"},{"issue":"6","key":"2026070211220692500_bib49","doi-asserted-by":"crossref","first-page":"e0130026","DOI":"10.1371\/journal.pone.0130026","article-title":"Impact of pre-transplant anti-T cell globulin (ATG) on immune recovery after myeloablative allogeneic peripheral blood stem cell transplantation","volume":"10","author":"Servais","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"2026070211220692500_bib50","first-page":"82","article-title":"Rabbit antithymocyte globulin induces rapid expansion of effector memory CD8 T cells without accelerating acute graft versus host disease","volume":"2","author":"Wittenbecher","year":"2013","journal-title":"Leuk Res Rep"},{"issue":"3","key":"2026070211220692500_bib51","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1600-6143.2005.00759.x","article-title":"Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion","volume":"5","author":"Pearl","year":"2005","journal-title":"Am J Transplant"},{"issue":"8","key":"2026070211220692500_bib52","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/leu.2012.66","article-title":"The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation","volume":"26","author":"Lion","year":"2012","journal-title":"Leukemia"},{"issue":"20","key":"2026070211220692500_bib53","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1182\/bloodadvances.2024015626","article-title":"Bone marrow and blood demonstrate distinct immune reconstitution patterns and correlations with relapse posttransplant","volume":"9","author":"DeWolf","year":"2025","journal-title":"Blood Adv"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/1\/130\/2531369\/blood_bld-2025-032587-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/1\/130\/2531369\/blood_bld-2025-032587-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:23:38Z","timestamp":1783005818000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/148\/1\/130\/567756\/CD28-CD8-Tem-cells-with-a-STAT1-dependent"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7,2]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025032587","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7,2]]},"published":{"date-parts":[[2026,7,2]]}}}